Medality Medical said the device, which was designed by its founder Mark Andrew, can gently and selectively extract excess mesenteric visceral fat, which has been associated with insulin
The post Medality Medical wins FDA IDE approval for reversal of type 2 diabetes clinical trial appeared first on Compelo Medical Devices.